The delivery of siBcl-2 by LHRH-QPAMAM reduces Bcl-2 expression in cancer cells by more than by 75% [87,88,103] and promotes accumulation in tumor and liver tissues in vivo [88]. The gene discussed is BCL2; the disease is cancer.